These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6279501)

  • 1. Antibodies to the alpha 1- and alpha 2-selective antagonists prazosin and yohimbine as probes of the alpha-adrenergic binding sites.
    Graham RM; Hess HJ; Haber E; Homcy CJ
    Hypertension; 1982; 4(3 Pt 2):183-7. PubMed ID: 6279501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H]yohimbine, and [3H]rauwolscine.
    Motulsky HJ; Insel PA
    Biochem Pharmacol; 1982 Aug; 31(16):2591-7. PubMed ID: 6291538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of alpha adrenoceptor subtypes in dog arteries by (3H) yohimbine and (3H) prazosin.
    Bobik A
    Life Sci; 1982 Jan; 30(3):219-28. PubMed ID: 6122151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two distinct populations of [3H]prazosin and [3H]yohimbine binding sites in the plasma membranes of rat mesenteric artery.
    Agrawal DK; Daniel EE
    J Pharmacol Exp Ther; 1985 Apr; 233(1):195-203. PubMed ID: 2984413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Adrenergic receptors in human adipocyte membranes: direct determination by [3H]yohimbine binding.
    Tharp MD; Hoffman BB; Lefkowitz RJ
    J Clin Endocrinol Metab; 1981 Apr; 52(4):709-14. PubMed ID: 6110673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
    Snavely MD; Insel PA
    Mol Pharmacol; 1982 Nov; 22(3):532-46. PubMed ID: 6296651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of agonists with platelet alpha 2-adrenergic receptors.
    Hoffman BB; Michel T; Brenneman TB; Lefkowitz RJ
    Endocrinology; 1982 Mar; 110(3):926-32. PubMed ID: 6120077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of subtype selectivity of alpha-adrenergic antagonists: comparison of selective and nonselective radioligands.
    Lavin TN; Hoffman BB; Lefkowitz RJ
    Mol Pharmacol; 1981 Jul; 20(1):28-34. PubMed ID: 6117003
    [No Abstract]   [Full Text] [Related]  

  • 9. Human platelet alpha 2-adrenergic receptors: labeling with 3H-yohimbine, a selective antagonist ligand.
    Daiguji M; Meltzer HY; U'Prichard DC
    Life Sci; 1981 Jun; 28(24):2705-17. PubMed ID: 6115296
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of subtypes of alpha-2 adrenoceptors in the human brain.
    Ordway GA; Jaconetta SM; Halaris AE
    J Pharmacol Exp Ther; 1993 Feb; 264(2):967-76. PubMed ID: 8382286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of 3H-prazosin binding to alpha 1-adrenoceptors in bovine teat muscles.
    Roets E; Peeters G
    Arch Int Pharmacodyn Ther; 1985 Jun; 275(2):189-98. PubMed ID: 2992402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal alpha-1 and alpha-2 adrenergic receptors: biochemical and pharmacological correlations.
    Schmitz JM; Graham RM; Sagalowsky A; Pettinger WA
    J Pharmacol Exp Ther; 1981 Nov; 219(2):400-6. PubMed ID: 6270306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
    Lanier SM; Hess HJ; Grodski A; Graham RM; Homcy CJ
    Mol Pharmacol; 1986 Mar; 29(3):219-27. PubMed ID: 3005829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in alpha adrenergic receptors in human cerebral arteries after subarachnoid hemorrhage.
    Tsukahara T; Taniguchi T; Fujiwara M; Handa H; Nishikawa M
    Stroke; 1985; 16(1):53-8. PubMed ID: 2981441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of alpha-adrenergic receptors in human brain and changes in Alzheimer-type dementia.
    Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
    J Neurochem; 1986 Oct; 47(4):1295-301. PubMed ID: 3018166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha 2-Adrenergic receptors in human polymorphonuclear leukocyte membranes.
    Panosian JO; Marinetti GV
    Biochem Pharmacol; 1983 Jul; 32(14):2243-7. PubMed ID: 6307315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different affinity states of alpha-1 adrenergic receptors defined by agonists and antagonists in bovine aorta plasma membranes.
    Jagadeesh G; Deth RC
    J Pharmacol Exp Ther; 1987 Nov; 243(2):430-6. PubMed ID: 2890755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of [3H]yohimbine binding to putative alpha-2 adrenergic receptors in neonatal rat lung.
    Latifpour J; Jones SB; Bylund DB
    J Pharmacol Exp Ther; 1982 Dec; 223(3):606-11. PubMed ID: 6292392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype.
    Bylund DB; Ray-Prenger C; Murphy TJ
    J Pharmacol Exp Ther; 1988 May; 245(2):600-7. PubMed ID: 2835476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.